We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUMZ icon
7326
PUT
Zumiez
ZUMZ
$328M
$3K ﹤0.01%
100
-1,400
-93% -$36.9K
SER icon
7327
Serina Therapeutics
SER
$31.5M
$3K ﹤0.01%
46
-136
-75% -$12.9K
KA
7328
DELISTED
Kineta, Inc. Common Stock
KA
$3K ﹤0.01%
28
-9
-24% -$1.07K
FNCB
7329
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$3K ﹤0.01%
429
-3,940
-90% -$30.3K
CCLP
7330
DELISTED
CSI Compressco LP
CCLP
$3K ﹤0.01%
1,000
-57,726
-98% -$188K
KRTX
7331
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3K ﹤0.01%
203
-11,297
-98% -$220K
MARK
7332
DELISTED
Remark Holdings, Inc.
MARK
$3K ﹤0.01%
308
-108
-26% -$975
SRT
7333
DELISTED
Startek Inc.
SRT
$3K ﹤0.01%
416
-3,735
-90% -$25.3K
CWBR
7334
DELISTED
CohBar, Inc. Common Stock
CWBR
$3K ﹤0.01%
89
-30
-25% -$1.37K
STCN
7335
DELISTED
Steel Connect, Inc. Common Stock
STCN
$3K ﹤0.01%
214
MGI
7336
DELISTED
MoneyGram International, Inc. New
MGI
$3K ﹤0.01%
706
-75,224
-99% -$263K
AMPE
7337
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
17
-34
-67% -$4.53K
HSTO
7338
CALL
DELISTED
Histogen Inc. Common Stock
HSTO
$3K ﹤0.01%
48
-39
-45% -$2.54K
XONE
7339
DELISTED
The ExOne Company
XONE
$3K ﹤0.01%
300
-5,091
-94% -$41.6K
ZAGG
7340
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$3K ﹤0.01%
500
-2,200
-81% -$14.2K
CEL
7341
DELISTED
Cellcom Israel, Ltd.
CEL
$3K ﹤0.01%
910
CLUB
7342
DELISTED
Town Sports International Holdings, Inc.
CLUB
$3K ﹤0.01%
1,634
-555
-25% -$979
MLNT
7343
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$3K ﹤0.01%
783
-363
-32% -$1.31K
NVTR
7344
DELISTED
Nuvectra Corporation Common Stock
NVTR
$3K ﹤0.01%
1,952
-4,476
-70% -$8.78K
DGL
7345
DELISTED
Invesco DB Gold Fund
DGL
$3K ﹤0.01%
60
PACD
7346
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$3K ﹤0.01%
749
-6,874
-90% -$48.4K
IID
7347
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$3K ﹤0.01%
500
CHIX
7348
DELISTED
Global X MSCI China Financials ETF
CHIX
$3K ﹤0.01%
212
+2
+1% +$31
GCVRZ
7349
CALL
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3K ﹤0.01%
4,447
ACRS icon
7350
Aclaris Therapeutics
ACRS
$750M
$2K ﹤0.01%
2,113
-14,741
-87% -$20.9K

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.